| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 01/09/2008 | EP1608647B1 5-phenylthiazole derivatives and their use as p13 kinase inhibitors |
| 01/09/2008 | EP1263730B1 Amine derivatives for the treatment of apoptosis |
| 01/09/2008 | EP1239877B1 Composition comprising a tnf-alpha inhibitor and an integrin alphavbeta3 receptor antagonist |
| 01/09/2008 | CN101100460A Method for producing rubber vulcanization accelerator |
| 01/09/2008 | CN100360528C Preparation of 4-amino-1-(2-methylol-1,3-oxapentane-5-group)-2(1H)-pyrimidone |
| 01/09/2008 | CN100360512C Biphenylmethyl-thiazolidinediones and analogues and their use as PPAR-gamma activators |
| 01/09/2008 | CN100360511C Method for synthesizing 4-methyl-5-methyol thiazole |
| 01/09/2008 | CN100360507C Inhibition of raf kinase using substituted heterocyclic ureas |
| 01/08/2008 | US7317107 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity |
| 01/08/2008 | US7317028 Antitumor agents; autoimmune disease; skin disorders; anticancer agents |
| 01/08/2008 | US7317024 Obesity, diabetes, inflammatory and immune diseases |
| 01/08/2008 | US7317007 Such as 4-(4-Methoxy-7-morpholin-4-yl-benzothiazol-2-ylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester; for prevention of illnesses based on the modulation of the adenosine system, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain |
| 01/08/2008 | CA2338600C Novel thiazolopyrimidine compounds |
| 01/08/2008 | CA2192433C Anti-herpesvirus compounds and methods for identyfying, making and using same |
| 01/03/2008 | WO2008002570A2 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | WO2008002569A2 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | WO2008000407A1 Inhibitors of cxcr2 |
| 01/03/2008 | WO2007127502A3 Polymorphic form of { 2-methyl-4- [ 4-methyl-2- ( 4-triflu0r0methylphenyl) thiazol -5- ylmethylthiol phenoxy }-acetic acid |
| 01/03/2008 | US20080004450 cyclization; deprotecting; treatment of cancer and cancer which has developed multidrug-resistant phenotype |
| 01/03/2008 | US20080004415 Non-linear optically active molecules, their synthesis, and use |
| 01/03/2008 | US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 01/03/2008 | US20080004301 Benzene Compound Having 2 or More Substituents |
| 01/03/2008 | US20080004290 Anti-Cancer Agents |
| 01/03/2008 | US20080004267 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | US20080004261 Calcitonin Gene-Related Peptide (CGRP); headaches, pain, hot flashes; compounds are based on 3-substituted-5-(piperidinocarbonylmethyl)-thiazolidin-4-one moiety and ring derivatives thereof |
| 01/03/2008 | CA2657107A1 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | CA2657096A1 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/02/2008 | EP1871752A1 Amidopropoxyphenyl orexin receptor antagonists |
| 01/02/2008 | EP1871744A1 New heterocyclylethylbenzamide derivatives |
| 01/02/2008 | CN101098862A New 3-phenylpropionic acid derivatives and their use as ppar-gamma rezeptor liganden |
| 01/02/2008 | CN101098698A 5-carboxamido substitued thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family |
| 01/02/2008 | CN101096365A Dehydrating and separating method for AE active ester centrifugal mother liquid mixed solvent |
| 01/02/2008 | CN101096364A New technique for catalytic synthesis of AE active ester |
| 01/02/2008 | CN101096363A 2,4,5-three-substituted thiazole compound, preparation method, medicament composition and pharmacy use thereof |
| 01/02/2008 | CN101096362A Method for preparing methylaminothiazolyloximate |
| 01/02/2008 | CN101095675A Dipeptidyl peptidase IV effectors |
| 01/02/2008 | CN100358901C Cross-linked glycopeptide-cephalosporin antibiotics |
| 01/02/2008 | CN100358887C M-aminophenol derivatives and coloring agents containing them |
| 01/02/2008 | CN100358867C Heterocyclic inhibitors of glycogen synthase kinase GSK-3 |
| 01/01/2008 | US7314950 Sulfinating a trans-alkyl 4-aminocyclohexanecarboxylate (formed by iminating the cis-analog with a benzaldehyde and hydrolyzing the product) with an alkanesulfinyl chloride and oxidizing the product to form an alkyl 4-alkylsulfonamidocyclohexanecarboxylate, which then may be hydrolyzed |
| 01/01/2008 | US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1 |
| 12/27/2007 | WO2007148835A1 Agent for overcoming resistance to anti-cancer agent |
| 12/27/2007 | WO2007148808A1 Tricyclic compound and pharmaceutical use thereof |
| 12/27/2007 | WO2007148787A1 Process for production of a polymorph of 2-(3-cyano-4- isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid |
| 12/27/2007 | WO2007148093A1 Antibacterial compositions |
| 12/27/2007 | WO2007147701A1 Azoline compounds for combating arthropod pests |
| 12/27/2007 | WO2007147336A1 Heterocyclic non-nucleoside compounds, their peparation, pharmaceutical composition and their use as antiviral agents |
| 12/27/2007 | WO2007092558A3 Sulfonamide derivatives to treat infection with hepatitis c virus |
| 12/27/2007 | WO2007047306A8 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 12/27/2007 | WO2004058735A3 Ligands of melanocortin receptors and compositions and methods related thereto |
| 12/27/2007 | US20070299263 Hydroxy Alkyl Amines |
| 12/27/2007 | US20070299115 (Hetero)Cyclyl(Thio) Carboxylic Acid Anilides For Controlling Pathogenic Fungi |
| 12/27/2007 | US20070299080 Benzamide derivatives and uses related thereto |
| 12/27/2007 | US20070299077 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 12/27/2007 | US20070299074 Guanidine Compounds, and Use Thereof as Binding partners for 5-Ht5 Receptors |
| 12/27/2007 | US20070299052 Inhibitors of IAP |
| 12/27/2007 | US20070298123 Anti-angiogenic compositions and methods of use |
| 12/27/2007 | US20070298065 2-Cyclopentyl-4-(4-phenoxyphenyl)thiazole-5-carboxamide; amidation; oxidation; cyclization; |
| 12/27/2007 | CA2657967A1 Cyclopentane derivatives as antiglaucoma agents |
| 12/27/2007 | CA2656264A1 Method for producing crystal polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid |
| 12/27/2007 | CA2655895A1 Agent for overcoming resistance to anti-cancer agent |
| 12/27/2007 | CA2655753A1 Tricyclic compound and pharmaceutical use thereof |
| 12/27/2007 | CA2655403A1 Antibacterial benzothiazoles and thiazolopyridines |
| 12/26/2007 | EP1869060A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 12/26/2007 | EP1868982A2 Compounds that stimulate glucose utilization and methods of use |
| 12/26/2007 | EP1868604A2 Regulation of protein synthesis by inhibition of eif4e-eif4g interaction |
| 12/26/2007 | EP1597248B1 Sulfonamide derivatives as ppar modulators |
| 12/26/2007 | EP1525193B1 Acylaminothiazole derivatives, preparation and therapeutic use thereof |
| 12/26/2007 | EP0804428B1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 12/26/2007 | CN101094830A Fused bicyclic carboxamide derivatives for use as CXCR2 inhibitors in the treatment of inflammation |
| 12/26/2007 | CN101092400A 黄嘌呤氧化酶抑制剂 Xanthine oxidase inhibitors |
| 12/26/2007 | CN100357449C Highly stable oxidative coupling dye for spectrophotometric |
| 12/26/2007 | CN100357283C Methionyl aminopeptidase inhibitor |
| 12/26/2007 | CN100357280C Dihydronaphthalene devivatives and drugs contanining these compounds as active ingrdeient |
| 12/25/2007 | US7312353 Cathespin cysteine protease inhibitors |
| 12/21/2007 | WO2007144174A1 Ethenyl carboxamide derivatives useful as microbiocides |
| 12/21/2007 | WO2007143822A1 Sulfamide and sulfamate derivatives as histone deacetylase inhibitors |
| 12/21/2007 | WO2007106469A3 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders |
| 12/21/2007 | WO2007099509A3 Primary amines as renin inhibitors |
| 12/21/2007 | WO2007062078A3 Thrombopoietin activity modulating compounds and methods |
| 12/21/2007 | WO2006108792A8 New heterocyclylethylbenzamide derivatives |
| 12/21/2007 | CA2655085A1 Cgrp receptor antagonists |
| 12/21/2007 | CA2654097A1 Ethenyl carboxamide derivatives useful as microbiocides |
| 12/20/2007 | US20070293542 Selective Cox-2 Inhibitors |
| 12/20/2007 | US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 12/20/2007 | US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine |
| 12/20/2007 | US20070293487 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 12/20/2007 | US20070293423 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
| 12/20/2007 | US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease |
| 12/19/2007 | EP1867684A1 Coloring matter for anisotropic coloring matter film, composition comprising said coloring matter, anisotropic coloring matter film, and polarizing element |
| 12/19/2007 | EP1866300A1 Arylsulfonyl benzofused heterocycles as 5-ht2a antagonists |
| 12/19/2007 | EP1866298A2 Hydroxysteroid dehydrogenase inhibitors |
| 12/19/2007 | EP1866297A1 Process for producing an aminomethyl thiazole compound |
| 12/19/2007 | EP1866296A1 Desferrithiocin polyether analogues |
| 12/19/2007 | EP1866294A1 Compounds comprising an oxazoline or thiazoline moiety, processes for making them, and their uses |
| 12/19/2007 | EP1866293A1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
| 12/19/2007 | EP1771426B1 Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1b (ptp1b) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes |
| 12/19/2007 | EP1664031B1 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors |
| 12/19/2007 | EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/19/2007 | EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |